login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
All US stocks
All Canadian stocks
All European stocks
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
NOVO-NORDISK A/S-SPONS ADR (NVO) Stock News
NYSE:NVO -
US6701002056
-
ADR
56.98
USD
+1.53 (+2.76%)
Last: 8/22/2025, 8:27:48 PM
57
USD
+0.02 (+0.04%)
After Hours:
8/22/2025, 8:27:48 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
NVO Latest News, Press Relases and Analysis
All
Press Releases
12 days ago - By: Chartmill
NOVO-NORDISK A/S-SPONS ADR (NYSE:NVO): A Strong Value Investment with Undervalued Potential
16 days ago - By: Chartmill
NOVO-NORDISK A/S-SPONS ADR (NYSE:NVO): A Top Pick for Affordable Growth Investors
2 days ago - By: THE ROSEN LAW FIRM, P. A.
NVO Investors Have Opportunity to Lead Novo Nordisk A/S Securities Fraud Lawsuit
2 days ago - By: The Motley Fool
- Mentions:
BRK
MCD
DIS
UNH
...
Warren Buffett Makes a Big Buy
2 days ago - By: Benzinga
- Mentions:
LLY
Options Corner: Embattled Drug Maker Novo Nordisk May Offer Speculators A Quick Profit-Scalping Opportunity
2 days ago - By: Benzinga
- Mentions:
GILD
ALC
AZN
BMY
...
10 Health Care Stocks With Whale Alerts In Today's Session
2 days ago - By: Faruqi & Faruqi LLP
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Novo Nordisk
2 days ago - By: Zacks Investment Research
- Mentions:
LLY
AMGN
VKTX
Is Orforglipron Pill Setback End of the Road for LLY's Obesity Plans?
2 days ago - By: Levi & Korsinsky, LLP
September 30, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against NVO
2 days ago - By: Zacks Investment Research
- Mentions:
UNH
REGN
CVS
The Zacks Analyst Blog Highlights Health Care Select Sector SPDR, SPDR S&P 500 ETF Trust, UnitedHealth, Regeneron, CVS Health and Novo Nordisk
3 days ago - By: Bragar Eagel & Squire
- Mentions:
ALT
SLQT
SPPI
Bragar Eagel & Squire, P.C. Reminds Investors of Novo, Altimmune, SelectQuote, and Spectrum that Lawsuits Have Been Filed and Encourages Investors to Contact the Firm
3 days ago - By: Zacks Investment Research
- Mentions:
LLY
VKTX
Post Obesity Pill Results Reveal: Buy, Sell or Hold VKTX Stock?
3 days ago - By: Faruqi & Faruqi, LLP
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Novo Nordisk
3 days ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Novo Nordisk A/S of Class Action Lawsuit and Upcoming Deadlines - NVO
3 days ago - By: Zacks Investment Research
- Mentions:
REGN
UNH
CVS
Is This the Right Time to Consider Healthcare ETFs?
3 days ago - By: Zacks Investment Research
- Mentions:
REGN
FDA Extends Review Period of REGN's Submission for Eylea HD
3 days ago - By: Yahoo Finance
- Mentions:
LLY
Jim Cramer on Novo Nordisk: “They Are Incredibly Poorly Run”
4 days ago - By: Robbins LLP
NVO STOCK: Robbins LLP Reminds NVO Stockholders of the Opportunity to Lead the Class Action Lawsuit Against Novo Nordisk A/S
4 days ago - By: Zacks Investment Research
- Mentions:
RIGL
AVDL
MDGL
Madrigal Gets Conditional Nod for MASH Drug Rezdiffra in EU
4 days ago - By: Zacks Investment Research
- Mentions:
LLY
VKTX
Viking Therapeutics' Stock Tanks on Mixed Data From Obesity Pill Study
4 days ago - By: Zacks Investment Research
- Mentions:
LLY
ABBV
AbbVie Rises 11.5% in a Month: Buy, Hold or Sell the Stock?
4 days ago - By: The Motley Fool
1 Reason to Buy NVO
5 days ago - By: Yahoo Finance
- Mentions:
LLY
VKTX
Why Novo Nordisk Stock Popped Today
5 days ago - By: Yahoo Finance
- Mentions:
HD
INTC
ORCL
AVGO
...
Stock Market Today: Home Depot, Intel, and Viking Therapeutics are on the move
19 days ago - By: Chartmill
NOVO-NORDISK A/S-SPONS ADR (NYSE:NVO): A High-Quality Dividend Stock with Strong Growth and Stability
Please enable JavaScript to continue using this application.